NCT06576648Recruiting
Thailand HIV and Stigma Reduction Study
Optimizing Mobile Interventions to Overcome Stigma and Promote HIV Prevention
Source: ClinicalTrials.gov · Last updated 31 Aug 2026
Brief summary (registry, in English)
This project will develop a multi-component, technology-delivered intervention designed to reduce HIV and intersectional stigma and improve the use of HIV pre-exposure prophylaxis (PrEP) among HIV-negative Thai vulnerable emerging adults (18-29 years).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 154 (estimated)
- First submitted
- 26 Aug 2024
- Start date
- 20 Feb 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- University of Massachusetts, Worcester
- Diseases
- HIV
- NCT number
- NCT06576648
What you commit to
- Study type: Interventional
- Planned participants: 154
- From 20 Feb 2025 to the primary completion date, 31 Dec 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Either not started PrEP or currently on PrEP but not adherent (taking ≤3 pills/week) in the past month.
Other illness
- Have a serious cognitive or psychiatric problem compromising ability to provide informed consent
- Have active suicidal ideation or major mental illness at the time of interview (these patients will be referred for treatment)
- Currently enrolled in another HIV intervention study.
- Healthcare providers Inclusion criteria
- Has provided HIV prevention or treatment services for TGW for at least one year Exclusion criteria
- Self-reported recent history of condomless sex
- Have a serious cognitive or psychiatric problem compromising ability to provide informed consent
- Have active suicidal ideation or major mental illness at the time of interview (these patients will be referred for treatment)
- Currently enrolled in another HIV intervention study.
Lab values
- Laboratory or clinical findings that would preclude PrEP initiation (e.g., decreased creatinine clearance)
- Laboratory-confirmed HIV-negative status
- Laboratory or clinical findings that would preclude PrEP initiation (e.g., decreased creatinine clearance)
Age
- Age 18 or above
- Ages between 18 and 29 years
Other
- None
- Aim 2 (Pilot RCT) Transgender women Inclusion criteria
- Male sex at birth
- Self-identifies as women, transgender women or culturally identifies with the female spectrum
- Able to understand, read and speak Thai
Who the study is looking for
- Ages between 18 and 29 years
- Male sex at birth
- Self-identifies as women, transgender women or culturally identifies with the female spectrum
- Laboratory-confirmed HIV-negative status
- Self-reported recent history of condomless sex
- Able to understand, read and speak Thai
- Either not started PrEP or currently on PrEP but not adherent (taking ≤3 pills/week) in the past month.
Criteria the registry did not label
- Aim 1 (Formative Research and Beta-Testing) Transgender women
Age in the registry: 18 years to 29 years · Sex: Male · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institute of HIV Research and Innovation Coordinator of this site? Confirm its status | Bangkok | Thailand | Recruiting |
| SWING Foundation Coordinator of this site? Confirm its status | Bangkok | Thailand | Recruiting |
| Rainbow Sky Association of Thailand Coordinator of this site? Confirm its status | Bangkok | Thailand | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.